CDIVX
Price
$12.29
Change
+$0.09 (+0.74%)
Updated
Jun 6 closing price
Net Assets
30.22M
VEXMX
Price
$143.25
Change
+$1.79 (+1.27%)
Updated
Jun 6 closing price
Net Assets
107.69B
Interact to see
Advertisement

CDIVX vs VEXMX

Header iconCDIVX vs VEXMX Comparison
Open Charts CDIVX vs VEXMXBanner chart's image
Copeland Dividend Growth Fund
Price$12.29
Change+$0.09 (+0.74%)
VolumeN/A
Net Assets30.22M
Vanguard Extended Market Index Investor
Price$143.25
Change+$1.79 (+1.27%)
VolumeN/A
Net Assets107.69B
CDIVX vs VEXMX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CDIVX vs. VEXMX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDIVX is a Buy and VEXMX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEXMX has more cash in the bank: 108B vs. CDIVX (30.2M). VEXMX pays higher dividends than CDIVX: VEXMX (1.08) vs CDIVX (0.27). CDIVX was incepted earlier than VEXMX: CDIVX (12 years) vs VEXMX (37 years). CDIVX (1.99) is less costly to investors than VEXMX (0.19). CDIVX is a more actively managed with annual turnover of: 32.00 vs. VEXMX (11.00). VEXMX has a lower initial minimum investment than CDIVX: VEXMX (3000) vs CDIVX (25000). VEXMX annual gain was more profitable for investors over the last year : 10.82 vs. CDIVX (-5.25). VEXMX return over 5 years is better than : 54.37 vs. CDIVX (16.95).
CDIVXVEXMXCDIVX / VEXMX
Total Expense Ratio1.050.19553%
Annual Report Gross Expense Ratio1.990.191,047%
Fund Existence12 years37 years-
Gain YTD1.161-1.826-64%
Front LoadN/AN/A-
Min. Initial Investment250003000833%
Min. Initial Investment IRAN/AN/A-
Net Assets30.2M108B0%
Annual Yield % from dividends0.271.0825%
Returns for 1 year-5.2510.82-49%
Returns for 3 years1.9126.317%
Returns for 5 years16.9554.3731%
Returns for 10 years-13.69108.97-13%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LOGSX20.56N/A
N/A
Live Oak Health Sciences
OEQIX8.34N/A
N/A
Oaktree Emerging Markets Equity I
POVSX29.69N/A
N/A
Putnam International Equity A
ABYSX20.41N/A
N/A
AB Discovery Value Advisor
AKREX69.19N/A
N/A
Akre Focus Retail